Tolemy Bio

Tolemy Bio develops AI-driven tools to design, optimize, and control cell culture processes for advanced therapies.

Health and bioManufacturing and industrial

Tolemy Bio has no funding amount on record yet; its latest known round is Pre Seed (May 2026). Recent Funding first saw it on October 2, 2026.

Raise history

1. May 12, 2026
   Pre Seed · amount undisclosed
   Source: crunchbase.com

Related ai companies

• GGood Tape$600K · Oct 2, 2026
• OOptimizeGEO.ai$80M · Oct 1, 2026
• 11club AI$2.2M · Oct 1, 2026
• PPredictive AIOct 1, 2026
• JJAOPS$260M · Oct 1, 2026
• EestaieOct 1, 2026
• OOpensOct 1, 2026
• KKeepsake Family HistoryOct 1, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/tolemy-bio.